Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients without any underlying liver disease and is known to be associated with a unique gene mutation. This cancer type is rare in Asia, with only a few cases being reported in Korea. We report a case of FLHCC in a young woman that successfully underwent surgical resection. The efficacy of alternative treatments, such as transarterial chemoembolization or systemic chemotherapies, has not yet been established. To conclude, early diagnosis and appropriate surgical resection are important for the treatment of FLHCC.
Citations
Citations to this article as recorded by
Metastatic Fibrolamellar Hepatocellular Carcinoma in a Young Adult: A Case Report and Narrative Review Roy El Darzi, Christopher Ashy, Ali Khrayzat, Sally Chahine, Ayman Tawil, Sally Temraz Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Erkennung und Unterscheidung von atypischen hepatozellulären Karzinomen Chiraz Ben-Salah, Philipp Mayer, Thomas Longerich, Miriam Klauß Die Radiologie.2026; 66(6): 481. CrossRef
Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal Mohamed Ismail , Sahiba Singh, Menna-Allah Elaskandrany , David s Kim, Yazan Abboud, Michael Bebawy, Abena Oduro, Ritik mahaveer Goyal, Omar Mohamed , Weizheng Wang Cureus.2024;[Epub] CrossRef